Projects and Grants per year
- 1 - 50 out of 2,102 results
Search results
-
Active
Targeting ABL1/2 And DDR1 Tyrosine Kinases for Treating NRAS-Mutant Melanoma
Plattner, R. (PI), Arays, R. (CoI), Liu, J. (CoI), Richards, D. (CoI) & Wang, C. (CoI)
6/1/25 → 6/1/29
Project: Research project
-
25-NHL-43-JJ-PMC (90014496LYM1001): A Phase 1b Multicenter, Open-label, Study of JNJ-90014496, an Autologous CD19/CD20 Bi-specific CAR-T Cell Therapy in Adult Participants with B-cell Non-Hodgkin Lymphoma
Iragavarapu, C. (PI)
Janssen Research and Development LLC
5/22/25 → 5/22/27
Project: Research project
-
Surveillance, Epidemiology, and End Results (SEER) Program
Durbin, E. B. (PI), Huang, B. (CoI), Shelton, B. (CoI), Ross, F. (Former CoI) & Tucker, T. (Former CoI)
5/1/25 → 4/30/26
Project: Research project
-
25-NHL-44-HR(GO45434): A Phase II, Open-Label, Multicenter Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Patients With Relapsed/Refractory Diffuse Large B-Cel
Iragavarapu, C. (PI)
4/28/25 → 4/28/27
Project: Research project
-
24-LEUK-27-DS(AC220-168): Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial Of Quizartinib Administered in Combination With Induction and Consolidation Chemotherapy and Administered as Maintenance Therapy in Adult Patients With Newly Diagnosed F
Qasrawi, A. (PI)
4/22/25 → 4/22/27
Project: Research project
-
24-HN-42-BT(BCA101X301): A Multicenter, Randomized, Double-blind, Phase 2/3 Study of Ficerafusp Alfa (BCA101) or Placebo in Combination with Pembrolizumab for First-Line Treatment of PD-L1-positive, Recurrent or Metastatic Head and Neck Squamous Cell Carc
Arnold, S. (PI)
Bicara Therapeutics Incorporated
4/21/25 → 4/21/27
Project: Research project
-
Targeting MNK/GRP78 Pathway to Disrupt Proteostasis Rewiring in Castration-Resistant Prostate Cancer
Li, Z. (PI), Liu, J. (CoI) & Liu, X. (CoI)
4/15/25 → 4/14/28
Project: Research project
-
Identification of NNMT as a New Target to Treat Triple-negative Breast Cancer
Zhou, B. (PI), Fan, W.-M. (CoI) & Wang, C. (CoI)
4/7/25 → 3/31/30
Project: Research project
-
Pathways to Prevention: Exploring Social Determinants of Health in Early Onset Colorectal Cancer
Moore, J. (PI), Bhakta, A. (CoI), Burris, J. (CoI) & Chen, L. (CoI)
4/1/25 → 3/31/27
Project: Research project
-
Experimental Manipulation of Sleep to Combat Epilepsy (RPA Pilot / Seed Project)
Sunderam, S. (PI) & Bauer, B. (CoI)
University of Kentucky Neuroscience Research Priority Area
3/15/25 → …
Project: Research project
-
24-MULTI-65-TB-PMC (TORL123-001): A Phase 1, First in Human, Dose-Escalation Study of TORL-1-23 in Participants With Advanced Cancer
Villano, PhD, J. (PI)
Translational Research in Oncology
2/19/25 → 2/19/27
Project: Research project
-
CCSG Pilot: The Cumulative Impact Of Air Pollution On Pediatric Brain Tumor In Kentucky
Lu, T. (PI), Christian, J. (CoI), Durbin, E. B. (CoI), Huang, B. (CoI), Liu, Y. (CoI) & Villano, PhD, J. (CoI)
2/1/25 → 1/31/26
Project: Research project
-
The cumulative impact of air pollution on pediatric brain tumor in Kentucky (RPA Pilot / Seed Project)
Lu, T. (PI)
University of Kentucky UNITE Research Priority Area
2/1/25 → 1/31/26
Project: Research project
-
FY25 Lung Cancer Screening Program Learning Collaborative C5546
Knight, J. (PI) & Mullett, T. (CoI)
KY Cabinet for Health and Family Services
1/28/25 → 6/30/26
Project: Research project
-
FY26 Lung Cancer Screening Program Learning Collaborative C5546
Knight, J. (PI) & Mullett, T. (CoI)
1/28/25 → 6/30/26
Project: Research project
-
24-NHL-40-AB (M22-128): A Phase 3, Multicenter, Randomized, Open-Label Study of Epcoritamab Plus Lenalidomide Compared to Rituximab Plus Gemcitabine and Oxaliplatin in Participants with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Iragavarapu, C. (PI)
1/15/25 → 1/15/27
Project: Research project
-
Optimizing the MLC-based Spatially Fractionated Radiotherapy (SFRT) Technique: Investigating the Radiobiological Response of Indirect Cell Kill Mechanisms in SFRT Treatment of Large and Bulky Tumors (Radiation Medicine and Markey Cancer Center Collaborative Bench to Bedside pilot) (RPA Pilot / Seed Project)
Pokhrel, D. (PI)
University of Kentucky Markey Cancer Center
1/1/25 → 12/31/25
Project: Research project
-
Determine How Collagen Lysyl Hydroxylase 2 Drives Metastasis
Guo, H. (PI), Chen, L. (CoI) & Wang, C. (CoI)
1/1/25 → 12/31/28
Project: Research project
-
FY25 Lung Cancer Screening Program Quality Project C5545
Knight, J. (PI), Mullett, T. (CoI) & Shelton, B. (CoI)
KY Cabinet for Health and Family Services
12/20/24 → 6/30/26
Project: Research project
-
Optimizing Treatment for Human Papillomavirus-Associated Oropharyngeal Cancer in Older Adults
McDowell, J. (PI)
Medical University of South Carolina
12/12/24 → 11/30/29
Project: Research project
-
24-GBM-16-NL (EF-41): A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Optune (TTFields, 200 kHz) Concomitant with Maintenance Temozolomide and Pembrolizumab Versus Optune Concomitant with Maintenance Temozolomide and Placebo for the Tre
Villano, PhD, J. (PI)
12/4/24 → 12/4/26
Project: Research project
-
24-LUN-139-BNT (BNT327-01): A Phase II, Multi-site, Open-label, Parallel Group Trial of BNT327 in Combination with Chemotherapy for Participants with Untreated Extensive-Stage Small-Cell Lung Cancer and Participants with Previously Treated Small-Cell Lung
Hao, Z. (PI)
11/25/24 → 11/25/26
Project: Research project
-
HPV16 E6 Seropositivity and ctHPVDNA for Early Detection of Oropharyngeal Cancer
Kuhs, K. (PI), Bhakta, A. (CoI), Chen, L. (CoI) & Windon, M. (CoI)
Army Medical Research and Development Command
11/15/24 → 11/14/27
Project: Research project
-
24-NHL-39-FTI-PMC(FT522-101): A Phase 1 Study of FT522 in Combination with Rituximab in Participants with Relapsed/Refractory B-Cell Lymphoma
Iragavarapu, C. (PI)
Fate Therapeutics Incorporated
10/28/24 → 10/28/26
Project: Research project
-
SHE (Summer Healthcare Experience) in Oncology
Vanderford, N. (PI)
10/1/24 → 8/31/29
Project: Research project
-
24-GI-135-AZ (D7025C00001): A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Global Study of Rilvegostomig in Combination with Chemotherapy as Adjuvant Treatment After Resection of Biliary Tract Cancer with Curative Intent (ARTEMIDE
Patel, R. (PI)
AstraZeneca Pharmaceuticals LP (domestic)
9/26/24 → 9/26/26
Project: Research project
-
24-LEUK-26-OV (OV-AML-1231): A Multicenter, Open-label, Randomized, Phase 2 Study of Venetoclax and Azacitidine Plus Cusatuzumab Versus Venetoclax and Azacitidine Alone in Newly Diagnosed AML Patients Who Are Not Candidates for Intensive Therapy
Qasrawi, A. (PI)
9/4/24 → 9/4/26
Project: Research project
-
24-HN-40-MSD (007-00): A Phase 2/3, Adaptive, Randomized, Open-Label, Clinical Study to Evaluate Neoadjuvant and Adjuvant V940 (mRNA-4157) in Combination with Pembrolizumab (MK- 3475) Versus Standard of Care, and Pembrolizumab Monotherapy in Participants
Arnold, S. (PI)
Merck Sharp & Dohme Corporation
9/3/24 → 9/3/26
Project: Research project
-
Developing New Therapeutic Approaches for BRAFV600E Colorectal Cancer
Zaytseva, Y. (PI), Lee, E. (CoI) & Wang, C. (CoI)
9/1/24 → 8/31/26
Project: Research project
-
Statewide Capacity Building and Quality Implementation of Lung Cancer Screening Utilizing the QUILS System
Knight, J. (PI), Mullett, T. (CoI) & Shelton, B. (CoI)
Bristol Myers Squibb Foundation Incorporated
9/1/24 → 8/31/28
Project: Research project
-
-
Research Triangle Center of Excellence in Regulatory Science and Innovation (CERSI)
Moga, D. (PI), Adatorwovor, R. (CoI), Freeman, P. (CoI), Lei, F. (CoI), Lofwall, M. (CoI) & Slavova, S. (CoI)
University of North Carolina Chapel Hill
9/1/24 → 8/31/25
Project: Research project
-
24-GI-136-AZ (D9802C0001): A Phase III Multi-center, Open-label, Sponsor-blinded, Randomized Study of AZD0901 Monotherapy Compared with Investigator s Choice of Therapy in Second- or Later-Line Adult Participants with Advanced/Metastatic Gastric or Gastr
Patel, R. (PI)
AstraZeneca Pharmaceuticals LP (domestic)
8/30/24 → 8/30/26
Project: Research project
-
-
Targeting Lung Fibrosis Using Epigenetic Therapy
Brainson, C. (PI), Allison, D. (CoI), Beswick, E. (CoI), Liu, J. (CoI), Sturgill, J. (CoI), Weiss, H. (CoI) & Waters, C. (Former CoI)
National Heart Lung and Blood Institute
8/15/24 → 7/31/28
Project: Research project
-
24-LEUK-25-KO-PMC (KO-MEN-007): Phase 1 Study of Venetoclax/Azacitidine or Venetoclax in Combination with Ziftomenib (KO-539) or Standard Induction Cytarabine/Daunorubicin (7+3) Chemotherapy in Combination with Ziftomenib for the Treatment of Patients wit
Qasrawi, A. (PI)
8/14/24 → 8/14/26
Project: Research project